Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Creatine Phosphate in Valve Surgery
NCT03186053Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jun 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of creatine phosphate in heart valve disease (2 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: serum cardiac troponin I at 24 hours. Status: unknown.
02
Drugs
creatine phosphate
03
Conditions
heart valve disease
Beyond the preview
Go deeper on NCT03186053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03186053.